Company Encyclopedia
View More
name
ChemPartner
300149.SZ
Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide. The company operates in two segments, Microecological Nutrition and Medical Business; and Pharmaceutical Research and Development Service and Production Outsourcing Business. It offers prebiotic products and the provision of microecological medical services.
1.585 T
300149.SZMarket value -Rank by Market Cap -/-

Financial Score

07/12/2025 Update
C
BiotechnologyIndustry
Industry Ranking49/81
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-12.04%D
    • Profit Margin-14.76%D
    • Gross Margin25.64%C
  • Growth ScoreC
    • Revenue YoY5.72%C
    • Net Profit YoY83.35%A
    • Total Assets YoY-7.75%D
    • Net Assets YoY-8.05%D
  • Cash ScoreD
    • Cash Flow Margin-677.50%E
    • OCF YoY5.72%C
  • Operating ScoreC
    • Turnover0.52C
  • Debt ScoreB
    • Gearing Ratio35.77%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    ChemPartner: Net loss of RMB 18.2908 million in the third quarter

    ChemPartner announced that its revenue for the third quarter was 283 million yuan, a year-on-year increase of 11.72%; the net profit loss was 18.2908 million yuan. Revenue for the first three quarters was 817 million yuan, a year-on-year increase of 13.68%; the net profit was 7.0913 million yuan, a year-on-year increase of 111.50%

    Zhitong·
    SZ
    300149
    +0.20%
    Zhitong·
    SZ
    300149
    +0.20%

    ChemPartner's subsidiary plans to invest 58 million yuan in an industrial fund focusing on innovative drugs

    ChemPartner's wholly-owned subsidiary Beihai ChemPartner has signed an agreement with Shenzhen Investment Holdings Donghai Investment and other partners to jointly invest in the establishment of Shenzhen Luohu Donghai ChemPartner Pharmaceutical Industry Partnership, with a total subscription amount of 200 million yuan, of which Beihai ChemPartner contributes 58 million yuan, accounting for 29%. The partnership will focus on investing in innovative drugs and medical devices, aiming to enhance the company's capital operation capabilities and competitiveness

    Zhitong·
    SZ
    300149
    +0.20%
    Zhitong·
    SZ
    300149
    +0.20%

    ChemPartner establishes a new company, including AI-related businesses

    According to the Qichacha APP, recently, Guangdong ChemPartner Investment Co., Ltd. was established with a registered capital of 10 million yuan. The business scope includes: technical consulting services for artificial intelligence public service platforms; information technology consulting services; information consulting services, etc. The equity penetration of Qichacha shows that the company is wholly owned by ChemPartner

    Zhitong·
    SZ
    300149
    +0.20%
    Zhitong·
    SZ
    300149
    +0.20%

    ChemPartner released its half-year performance, turning a profit of 25.3821 million yuan

    According to the Zhitong Finance APP, ChemPartner released its semi-annual report for 2025, showing an operating income of 534 million yuan, a year-on-year increase of 14.75%. The net profit attributable to shareholders of the listed company was 25.3821 million yuan. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 6.7923 million yuan. The basic earnings per share were 0.051 yuan

    Zhitong·
    SZ
    300149
    +0.20%
    Zhitong·
    SZ
    300149
    +0.20%

    The research enthusiasm for star companies is high, and leading enterprises frequently release positive signals

    This week, 125 listed companies disclosed institutional research minutes, with nearly 40% of stocks achieving positive returns. Defu Technology and VGT rose more than 20%, while ChemPartner, DAYANG BIOTECH, ALD, and 7 other stocks rose more than 10%. The median price change of the surveyed stocks was -1.51%

    Wallstreetcn·
    SZ
    300149
    +0.20%
    SZ
    003017
    +2.73%
    SZ
    300696
    -0.04%
    Wallstreetcn·
    SZ
    300149
    +0.20%
    SZ
    003017
    +2.73%
    SZ
    300696
    -0.04%
    © 2025 Longbridge｜Disclaimer